New Delhi, April 1 – The Controller General of Drugs in India has increased regulatory scrutiny against the unauthorized sale and promotion of drugs for type 2 diabetes, also known as GLP-1 drugs, the government said on Wednesday.In recent weeks, 49 businesses across the country, including...
cardiology
diabetes
drug marketing
drug regulation
drug sales
endocrinologists
glp-1 drugs
glucagon-like peptide-1 receptor agonists
india
internal medicine
medical specialties
pharmaceuticals
prescriptiondrugs
regulatory inspections
type 2 diabetes
weight loss
Washington, March 26 – A group of US senators has urged federal regulators to take action against the illegal online sale of abortion pills, highlighting links to overseas supply chains, including India.In a letter to Food and Drug Administration (FDA) Commissioner Martin Makary on Wednesday...
abortion pills
chemical abortion
drug enforcement
drug regulation
drug supply chains
fda
federal regulation
india
medical supervision
mifepristone
misoprostol
online pharmacies
prescriptiondrugs
telehealth
united states
women's health
The Drugs Controller of India has intensified regulatory oversight against the unauthorized sale and promotion of GLP-1-based weight loss drugs. This move comes amid growing concerns over the increasing availability of multiple generic versions of these drugs in the Indian market, through retail...
adverse effects
cardiologists
drug promotion
drug sales
drugs controller of india
endocrinologists
glp-1 drugs
healthcare regulation
india
internal medicine specialists
medical supervision
pharmaceutical supply chain
prescriptiondrugs
regulatory oversight
weight loss drugs
New Delhi, February 17 The apex drug regulator, CDSCO, has approved three drugs – Orlistat, Tirzepatide, and Semaglutide – for weight loss treatment in the country, which can be sold in retail with a doctor's prescription, Minister of State for Health, Anupriya Patel, said on Tuesday.All drugs...
New Delhi, March 17 Fake and falsified obesity drugs could be prompting a public health concern driven by high prices, a lack of insurance, and the desire to lose weight, according to a world report article published in The Lancet journal.Author Sophie Cousins, an Australian writer and health...
cardiovascular health
counterfeit drugs
diabetes treatment
drug safety
fda warning
glp-1 receptor agonists
mexico
mounjaro
obesity drugs
ozempic
pharmaceutical fraud
prescriptiondrugs
public health
united states
weight loss
world health organization
Washington, March 12 – US President Donald Trump told supporters at a rally in Ohio that the United States was experiencing an economic surge driven by tax cuts, new investments, and expanded energy production, as he defended his policies and urged voters to back Republicans in upcoming...
apple inc.
corporate investment
donald trump
economic policy
energy production
ford motor company
government initiatives
kentucky
logistics industry
military operations
ohio
political campaigns
prescriptiondrugs
tax cuts
united states economy
New Delhi, March 11 The apex drug regulator, CDSCO, has issued an advisory, directing that weight-loss drugs, specifically GLP-1 medications, must only be sold with a prescription from a registered medical practitioner.It cautioned pharmaceutical companies against "directly or indirectly"...
Washington, February 20 – President Donald Trump said he threatened to impose a 100% tariff on French wine and champagne in order to force changes in global drug pricing, offering a vivid example of how he uses trade leverage to reshape international economic arrangements.Speaking at a steel...
donald trump
drug pricing
economic policy
european union
france-united states relations
germany
international trade
pharmaceutical industry
prescriptiondrugs
spain
steel industry
tariffs
trade negotiations
united states trade policy
us supreme court
wine tariffs